The competing renewal of this Program Project builds on important research findings from the initial funding period that advanced understanding of the intra-neuronal processing of the amyloid precursor proteins (APP) to generate alphabeta peptides, including a formic acid soluble pool of Abeta, and the role of human neuron derived alpha beta in the induction of neuron degeneration of and other pathologies found in the Alzheimer's disease (AD) brain. Based on their data, the investigators in the competing renewal application view the accumulation of extracellular Abeta deposits as necessary, but not sufficient to induce neurons to degenerate in AD. Provocative data on the intra-neuronal generation of amyloidogenic Abeta1-42 in vitro in human neuron-like NT2N cells and the dramatic augmentation of neuron death by traumatic brain injury (TBI) in transgenic mice prior to the formation of Alphabeta deposits in these mice are reported here, and this has led the investigators to propose a novel """"""""two hit"""""""" hypothesis to explain how Abeta could compromise the viability of neurons in AD. Specifically, they propose that neurons have a latent vulnerability to the toxic effects of high concentrations of amyloidogenic alphabeta (the """"""""first hit""""""""), but this vulnerability only becomes manifest when these neurons are subjected to a second perturbation (i.e. the """"""""second hit"""""""") such as TBI or cellular stress. Moreover, based on studies from the previous funding period of this Program Project, it is reasonable to consider the intra-neuronal milieu as the site wherein the """"""""first hit"""""""" initially occurs. To test this hypothesis, the investigators use complementary research strategies to pursue 4 separate Projects: 1) """"""""Biosynthesis And Processing Of Abeta In NT2N Cells"""""""" (R.W. Doms); 2) """"""""Regulation of Intra-neuronal Abeta In Vitro"""""""" (V.M.-Y. Lee); 3) """"""""Signal Transduction of APP Secretion in NT2N Cells"""""""" (B.A. Wolf); 4) """"""""Traumatic Brain Injury and Alzheimer's Disease"""""""" (J.Q. Trojanowski). With the support of an Administrative and a Neuroscience Core, the investigators of this Program Project will determine how the insidious, age-dependent accumulation of intra-neuronal Abeta (""""""""first hit"""""""") becomes toxic to selectively vulnerable neurons following the exposure of these neurons to another insult (i.e. the """"""""second hit""""""""), and the accomplishment of these studies is expected to have implications of understanding and treating AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG011542-07
Application #
6055382
Study Section
National Institute on Aging Initial Review Group (NIA)
Project Start
1993-09-01
Project End
2003-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
7
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Brunden, Kurt R; Ballatore, Carlo; Lee, Virginia M-Y et al. (2012) Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies. Biochem Soc Trans 40:661-6
Hurtado, David E; Molina-Porcel, Laura; Carroll, Jenna C et al. (2012) Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease. J Neurosci 32:7392-402
Xu, Shaohua; Brunden, Kurt R; Trojanowski, John Q et al. (2010) Characterization of tau fibrillization in vitro. Alzheimers Dement 6:110-7
Brunden, Kurt R; Ballatore, Carlo; Crowe, Alex et al. (2010) Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors. Exp Neurol 223:304-10
Hurtado, David E; Molina-Porcel, Laura; Iba, Michiyo et al. (2010) A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Am J Pathol 177:1977-88
Chen, Xiao-Han; Johnson, Victoria E; Uryu, Kunihiro et al. (2009) A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol 19:214-23
Brunden, Kurt R; Trojanowski, John Q; Lee, Virginia M-Y (2009) Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov 8:783-93
Shineman, Diana W; Dain, Aleksandra S; Kim, Minkyu L et al. (2009) Constitutively active Akt inhibits trafficking of amyloid precursor protein and amyloid precursor protein metabolites through feedback inhibition of phosphoinositide 3-kinase. Biochemistry 48:3787-94
Crowe, Alex; Huang, Wenwei; Ballatore, Carlo et al. (2009) Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening. Biochemistry 48:7732-45
Kim, Minkyu L; Zhang, Bin; Mills, Ian P et al. (2008) Effects of TNFalpha-converting enzyme inhibition on amyloid beta production and APP processing in vitro and in vivo. J Neurosci 28:12052-61

Showing the most recent 10 out of 94 publications